Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
about
Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasisuPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinInterleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expressionBi-module sensing device to in situ quantitatively detect hydrogen peroxide released from migrating tumor cellsInhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cellsInvestigating contactless high frequency ultrasound microbeam stimulation for determination of invasion potential of breast cancer cells.Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulinsHOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression.SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cellsA novel network profiling analysis reveals system changes in epithelial-mesenchymal transitionAberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.Cyclin D1, Id1 and EMT in breast cancer.Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2.Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma.Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slugDecreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells.Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expressionImpaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator ExpressionNew mechanistic insights of integrin β1 in breast cancer bone colonizationImbalanced expression of mitogen-activated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma.MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinomaStimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathwayXPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression.High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.Staurosporine Induced Apoptosis May Activate Cancer Stem-Like Cells (CD44(+)/CD24(-)) in MCF-7 by Upregulating Mucin1 and EpCAM.Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.ERK5 negatively regulates tobacco smoke-induced pulmonary epithelial-mesenchymal transition.Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathwayIdentification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells.Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models.SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma.
P2860
Q24630773-7633661B-E386-4F61-8078-C02C3B48D9BAQ28237374-4B09342D-34A5-4DD2-8BFD-5E25203E8654Q28385396-6A7C225A-D719-46A3-980F-9E985924FB2AQ28390678-22CC12D0-CBE2-41BF-8510-B015661B4FA3Q28395408-1BB17A47-0CC3-4AC6-A907-FDAB649877DAQ28542858-4152A599-E162-47B7-968D-D1D5A9CA906FQ30446822-733188A9-F555-46AC-A707-42DB2017B1B7Q30650458-8162023A-B85C-4E0C-B7F8-F9FEF1FD46BCQ33757052-558A80FD-F372-4C56-ADAC-175BB12F7167Q33891236-FDF9246E-EE93-4D00-A620-D4D5E4F5201EQ33936945-B60EADCF-D391-4332-9F36-0EFEF286F049Q34000057-6F09F698-6DCE-4F01-8B17-FD929A52E667Q34034112-16378902-4B2F-43B9-9F79-486D721CA14EQ34047362-ED771F80-7232-493C-8CA3-D6B65415BDBDQ34221160-0322A9CD-18E1-4D6B-89A4-5F360D81FB3EQ34320700-D9A1E3B1-1851-40C1-A9E0-2EB6826CC5BBQ34766871-BB3FBDB1-B98E-4198-9C2C-5B2614F9D8D0Q34892464-BECD81C7-F91C-4008-B636-9C5C86DEDD98Q34924229-A2BAA848-2DCA-4B6C-ABB8-95DC6D72EEFFQ35034871-C3A70779-64EF-4D98-91CE-167B6B7B63E6Q35238461-BCC77538-4EFB-41BE-990D-942C18B4FFB1Q35301861-46B6EA3C-6EBE-4973-8210-8F86C4C93D10Q35368044-A9D246FD-01A6-4F6F-B0A8-6A8CEEA28A37Q35610049-CA7EF7B6-3472-49CB-BDF9-754D1DAE0D99Q35740253-CA76CB41-63F8-4036-AD6F-2D495A98101FQ35832914-80EE321C-63CA-42AC-9C62-71EE3E8FCB66Q36003843-0A6B730F-E369-4652-A563-66D007D416AAQ36048537-836FB246-E743-4D82-8F51-56A25482C035Q36050039-AC9CD4E1-870D-4E4E-A774-D12089363B96Q36051868-E7FB81B9-AE72-4395-AB9E-D3F889C22274Q36260600-AE103541-1B29-4D95-9724-F3C89BD4D4EEQ36502514-AE51BBEA-1B3C-405C-95A0-53DAC83BAAF9Q36729649-6055B834-0A76-4140-B6B0-32DBA95EA735Q36734197-2D9D1E20-9340-4D0B-88F6-237BEB34E799Q36760840-52D42212-72C0-4ED5-9578-BE6BDCFACCCEQ36862768-30AAC5E5-560F-4977-BF4F-1FD3CF408E24Q37162398-B73A40BA-7F16-427F-A3A4-92FCA49BA140Q37374606-BD82BACC-B45E-47E2-AF4B-63829456A56BQ37421431-7879D9E1-22F3-4224-986C-C8CB533CB28DQ37536912-BC4B77B7-9E88-4AB2-BA89-287FAAE7BB0E
P2860
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extracellular signal-regulated ...... y maintaining slug expression.
@en
Extracellular signal-regulated ...... y maintaining slug expression.
@nl
type
label
Extracellular signal-regulated ...... y maintaining slug expression.
@en
Extracellular signal-regulated ...... y maintaining slug expression.
@nl
prefLabel
Extracellular signal-regulated ...... y maintaining slug expression.
@en
Extracellular signal-regulated ...... y maintaining slug expression.
@nl
P2093
P2860
P1433
P1476
Extracellular signal-regulated ...... by maintaining slug expression
@en
P2093
Genfeng Zhu
Haoming Chen
Ravi N Padia
Shuang Huang
Zheng Dong
Zhixing K Pan
P2860
P304
P356
10.1158/0008-5472.CAN-09-1950
P407
P50
P577
2009-12-01T00:00:00Z